Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nutres.2020.12.014 http://scihub22266oqcxt.onion/10.1016/j.nutres.2020.12.014 33592454!7881295!33592454     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nutr+Res 2021 ; 87 (ä): 1-12 Nephropedia Template TP {{tp|p=33592454|t=2021. Probiotics: A potential immunomodulator in COVID-19 infection management |pdf=|usr=}}{{33592454}} gab.com Text Probiotics: A potential immunomodulator in COVID-19 infection management JO: Nutr Res http://www.kidney.de/pget.php?&tw=1&pmid=33592454 #FOAvip COVID-19 caused by SARS-CoV-2 is an ongoing global pandemic. SARS-CoV-2 affects the human respiratory tract's epithelial cells, leading to a proinflammatory cytokine storm and chronic lung inflammation. With numerous patients dying daily, a vaccine and specific antiviral drug regimens are being explored. Probiotics are live microorganisms with proven beneficial effects on human health. While probiotics as nutritional supplements are long practiced in different cuisines across various countries, the emerging scientific evidence supports the antiviral and general immune-strengthening health effects of the probiotics. Here, we present an overview of the experimental studies published in the last 10 years that provide a scientific basis for unexplored probiotics as a preventive approach to respiratory viral infections. Based on collated insights from these experimental data, we identify promising microbial strains that may serve as lead prophylactic and immune-boosting probiotics in COVID-19 management. Twit Text FOAVip Probiotics: A potential immunomodulator in COVID-19 infection management ????Nutr Res http://www.kidney.de/pget.php?&tw=1&pmid=33592454 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33592454 #FOAvip English Wikipedia <ref>{{Cite pmid|33592454}}</ref> Probiotics: A potential immunomodulator in COVID-19 infection management #MMPMID33592454 Singh K; Rao A Nutr Res 2021[Mar]; 87 (ä): 1-12 PMID33592454show ga COVID-19 caused by SARS-CoV-2 is an ongoing global pandemic. SARS-CoV-2 affects the human respiratory tract's epithelial cells, leading to a proinflammatory cytokine storm and chronic lung inflammation. With numerous patients dying daily, a vaccine and specific antiviral drug regimens are being explored. Probiotics are live microorganisms with proven beneficial effects on human health. While probiotics as nutritional supplements are long practiced in different cuisines across various countries, the emerging scientific evidence supports the antiviral and general immune-strengthening health effects of the probiotics. Here, we present an overview of the experimental studies published in the last 10 years that provide a scientific basis for unexplored probiotics as a preventive approach to respiratory viral infections. Based on collated insights from these experimental data, we identify promising microbial strains that may serve as lead prophylactic and immune-boosting probiotics in COVID-19 management. |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19/immunology/virology[MESH] |Humans[MESH] |Immunologic Factors/*therapeutic use[MESH] |Lactobacillus[MESH] |Lung/*virology[MESH] |Pandemics[MESH] |Probiotics/*therapeutic use[MESH]Probiotics: A potential immunomodulator in COVID-19 infection manageme(epmc).pdf DeepDyve Pubget Overpricing